Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiong Wu
Observed name:
Wu, Jiong
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
The University of Texas MD Anderson Cancer Center,
Fudan University,
Chinese PLA General Hospital,
Fudan University Shanghai Cancer Center,
Chongqing Three Gorges Central Hospital
show all 6
ORCID:
0000-0002-8103-0505
Observed ORCIDs:
0000-0002-8103-0505,
0000-0002-8155-9126
OpenAlex ID:
A5040980728
The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia
2020
·
Kunhua Li
, Jiong Wu
, et al.
·
Investigative Radiology
·
1,384
Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features
2020
·
Jiong Wu
, Xiaojia Wu
, et al.
·
Investigative Radiology
·
688
Free Flap Monitoring Using Near-Infrared Spectroscopy: A Systemic Review
2015
·
Ying Chen
, Zhenzhou Shen
, et al.
·
Annals of Plastic Surgery
·
111
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified
2007
·
Wen-Feng Li
, Zhen Hu
, et al.
·
Breast Cancer Research and Treatment
·
97
Regulation and localization of CAS substrate domain tyrosine phosphorylation
2003
·
P Fonseca
, Nah-Young Shin
, et al.
·
Cellular Signalling
·
70
Antibiotic prophylaxis in prosthesis-based mammoplasty: A systematic review
2015
·
Naisi Huang
, Mengying Liu
, et al.
·
International Journal of Surgery
·
47
PDF
Role of BC040587 as a predictor of poor outcome in breast cancer
2014
·
Yayun Chi
, Sheng Huang
, et al.
·
Cancer Cell International
·
32
PDF
Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China
2014
·
Fang-Jing Ma
, Zhe-Bin Liu
, et al.
·
OncoTargets and Therapy
·
24
PDF
Critical role of CDK11p58 in human breast cancer growth and angiogenesis
2015
·
Yayun Chi
, Sheng Huang
, et al.
·
BMC Cancer
·
21
PDF
Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis
2016
·
Yi Fu
, Hao-jie Peng
, et al.
·
European Radiology
·
19
[Current trends of breast reconstruction after mastectomy for breast cancer patients in China: a survey report].
2014
·
Ying Chen
, Jiajian Chen
, et al.
·
PubMed
·
18
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
2025
·
Yin Liu
, Yue Gong
, et al.
·
BMJ
·
15
PDF
Expert consensus on the clinical diagnosis and targeted therapy of HER2 breast cancer (2023 edition)
2022
·
Jianbin Li
, Xiaojia Wang
, et al.
·
Translational Breast Cancer Research
·
14
PDF
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study
2025
·
Li Chen
, Wen‐Ya Wu
, et al.
·
癌症:英文版
·
12
PDF
Abstract PD8-08: Pyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study
2022
·
Jiong Wu
, Zhenzhen Liu
, et al.
·
Cancer Research
·
12
Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival
2021
·
Pei Li
, Benlong Yang
, et al.
·
Frontiers in Cell and Developmental Biology
·
11
Abstract OT1-12-04: A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP compared with ddAC-THP in patients with high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)
2022
·
Nadia Harbeck
, Jean-François Boileau
, et al.
·
Cancer Research
·
10
Evaluation of the safety, pharmacokinetics, and efficacy of JSKN003 in patients with advanced solid tumors: A phase I/II clinical study.
2024
·
Xiaojun Liu
, Jian Zhang
, et al.
·
Journal of Clinical Oncology
·
9
PDF
Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer
2021
·
Jingyan Xue
, Sheng Huang
, et al.
·
Frontiers in Oncology
·
9
Abstract PS08-06: A Phase Ib/II Study to Assess the Safety and Efficacy of PM8002 (Anti-PD-L1 x VEGF-A Bispecific Antibody) in Combination with Nab-Paclitaxel for First Line Treatment of Locally Advanced or Metastatic Triple-Negative Breast Cancer
2024
·
Jiong Wu
, Jian Zhang
, et al.
·
Cancer Research
·
8
Deadlock of proctologic practice in Italy during COVID-19 pandemic: a national report from ProctoLock2020
2020
·
Gaetano Gallo
, Alessandro Sturiale
, et al.
·
Updates in Surgery
·
8
LINC01235 Promotes Clonal Evolution through DNA Replication Licensing‐Induced Chromosomal Instability in Breast Cancer
2025
·
Qi Zhang
, Xuliren Wang
, et al.
·
Advanced Science
·
7
PDF
Izalontamab brengitecan (iza-bren) versus physician’s choice of chemotherapy in patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC): A randomized phase III study.
2026
·
Jiong Wu
, Jian Zhang
, et al.
·
Journal of Clinical Oncology
·
6
Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer
2022
·
Xuliren Wang
, Fangdie Ye
, et al.
·
Frontiers in Genetics
·
6
PDF
Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study
2025
·
Yongsheng Wang
, Xi Wang
, et al.
·
Journal of the National Cancer Center
·
5
Show more works
View as search
Works count:
87
Citation count:
2,700
H-index:
13
I10-index:
17
Year
Topic
Type